{
    "2019-07-09": [
        [
            {
                "time": "2019-07-09",
                "original_text": "研发投入近4000万，恒瑞子公司抗癌药首仿上市！同品种天晴/齐鲁在审！",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "抗癌药",
                        "首仿",
                        "研发投入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "3年亏损逾9亿，百奥泰选用第5套标准闯关科创板 亏损",
                "features": {
                    "keywords": [
                        "百奥泰",
                        "科创板",
                        "亏损"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "恒瑞重磅首仿药获批 国内药企注册进度几何？",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "首仿药",
                        "获批"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "恒瑞医药（600276.SH）：醋酸阿比特龙片获药品注册批件",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "醋酸阿比特龙片",
                        "注册批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "谁在接盘新城? \"黑天鹅\"后新城发展与新城悦明显放量",
                "features": {
                    "keywords": [
                        "新城",
                        "黑天鹅",
                        "放量"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "恒瑞医药：仿创结合持续推进 买入评级",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "仿创结合",
                        "买入评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "最新公告透露利好 15只个股有望爆发（07.09）",
                "features": {
                    "keywords": [
                        "公告",
                        "利好",
                        "个股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "恒瑞卡瑞利珠单抗二线治疗晚期食管鳞癌达主要终点",
                "features": {
                    "keywords": [
                        "恒瑞",
                        "卡瑞利珠单抗",
                        "食管鳞癌",
                        "主要终点"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-09",
                "original_text": "格力拟斥资2亿元入股新疆众和成第三大股东，第一大股东特变电工持股升至30.85%；多家券商披露6月业绩；平安再度耗资超5亿回购",
                "features": {
                    "keywords": [
                        "格力",
                        "新疆众和",
                        "特变电工",
                        "券商",
                        "平安",
                        "回购"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "家电",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}